Back to search
FDAFDA · Food and drugs·Recall number Z-0268-2027

Xact mole marker for mammography Model/Catalog Number: M15RM

Published October 28, 2026 · Recall initiated: September 22, 2026

Summary

FDA records medical device Class II recall Z-0268-2027, published October 28, 2026 and initiated September 22, 2026. Recalling firm: Solstice Corporation; Status: Ongoing; Reported quantity: 736; Lot: part #: M15RM; UDI-DI: 00854623006068; UPC-A; lot #: M15RM26A. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

The radiopaque material may detach from the marker. In some cases, artifact was noted and attributed to the detached material.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Solstice Corporation
Distributor
Worldwide - US Nationwide distribution in the states and territory of CA, FL, IL, IN, MN, MO, NY, OH, PA, TX, WV and Puerto Rico. The country of Canada.
Lot
part #: M15RM; UDI-DI: 00854623006068; UPC-A; lot #: M15RM26A;
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Xact mole marker for mammography Model/Catalog Number: M15RM recalled?

Yes. FDA published recall Z-0268-2027 on October 28, 2026. Reported hazard: The radiopaque material may detach from the marker. In some cases, artifact was noted and attributed to the detached material.

What should I do if I have this product?

Voluntary: Firm initiated · Letter